BIG HEALTHCARE COMPANIES CONTINUED INTEREST IN EMERGING COMPANIES. Yes, empty pipelines and inefficient discovery programs make for this continuing trend and symbiotic relationship; and emerging companies need both the capital and the marketing muscle to continue to do what they do best: innovate cheaply.
http://lnkd.in/qi6ZQb